The Ameliorative Role of Eugenol against Silver Nanoparticles-Induced Hepatotoxicity in Male Wistar Rats

Figure 12

Immunohistochemical expression of P53 in hepatic tissues revealing (a and b) weak immunostainability in the control and Eug-treated groups, respectively; (c) moderate positive immunostainability in the AgNPs-low-dose-treated group; (d) relatively strong positive immunoreaction in the AgNPs-high-dose-treated group; (e) weak positive affinity for P53 in the Eug + ANPs-low-dose-treated group, (f) moderate immunoreactivity in the Eug + ANPs-high-dose-treated group; (g) negative immunostaining in negative control.

(a)

(b)

(c)

(d)

(e)

(f)

(g)